Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion

Secretory leukocyte peptidase inhibitor (SLPI) is a biomarker present in the respiratory tract that protects against tissue destruction and aids in wound healing. We examined whether SLPI in pleural effusion can be used to distinguish benign asbestos pleural effusion (BAPE) from early-stage malignan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishimoto, Takumi, Kojima, Yoko, Fujimoto, Nobukazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217519/
https://www.ncbi.nlm.nih.gov/pubmed/34155270
http://dx.doi.org/10.1038/s41598-021-92289-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217519/
https://www.ncbi.nlm.nih.gov/pubmed/34155270
http://dx.doi.org/10.1038/s41598-021-92289-7

Ejemplares similares